Skip to main content

Table 4 Unmet information needs

From: A survey of cancer patients’ unmet information and coordination needs in handovers – a cross-sectional study

 

Overall unmet information needs

Unmet information needs at hospital discharge#

Unmet information needs in handovers between internal hospital departments##

Unmet information needs in handovers between hospitals###

 

N (%)

OR (95% CI)

ORadja(95% CI)

N (%)

OR (95% CI)

ORadja(95% CI)

N (%)

OR (95% CI)

ORadja(95% CI)

N (%)

OR (95% CI)

ORadja(95% CI)

Demographic characteristics

Gender

 Women

19 (19%)

1.00

1.00

14 (16%)

1.00

1.00

8 (12%)

1.00

1.00

12 (13%)

1.00

1.00

 Men

4 (12%)

0.57 (0.18; 1.83)

1.10 (0.31; 3.93)

4 (25%)

1.71 (0.48; 6.09)

2.24 (0.58; 8.64)

3 (21%)

2.05 (0.47; 8.94)

3.31 (0.66; 16.59)

4 (12%)

0.97 (0.29; 3.23)

2.77 (0.63; 11.20)

Age

 <60 years of age

13 (33%)

1.00

1.00

9 (26%)

1.00

1.00

6 (23%)

1.00

1.00

9 (24%)

1.00

1.00

 ≥60 years of age

10 (11%)

0.24*(0.10; 0.62)

0.26*(0.10; 0.70)

9 (13%)

0.42 (0.15; 1.19)

0.36 (0.12; 1.07)

5 (9%)

0.33 (0.09; 1.19)

0.26 (0.07; 1.05)

7 (8%)

0.27*(0.09; 0.79)

0.23*(0.07; 0.80)

Marital status

 No partner

8 (29%)

1.00

1.00

7 (29%)

1.00

1.00

2 (13%)

1.00

1.00

5 (19%)

1.00

1.00

 Partner

15 (15%)

0.43 (0.16; 1.16)

0.39 (0.13; 1.16)

11 (14%)

0.40 (0.13; 1.18)

0.39 (0.12; 1.24)

9 (13%)

1.01 (0.19; 5.23)

0.63 (0.10; 3.78)

11 (11%)

0.54 (0.17; 1.71)

0.47 (0.12; 1.88)

Education

 Not higher education

7 (10%)

1.00

1.00

6 (12%)

1.00

1.00

4 (9%)

1.00

1.00

2 (3%)

1.00

1.00

 Higher education

16 (29%)

3.60*(1.36; 9.52)

3.41*(1.23; 9.44)

12 (24%)

2.43 (0.83; 7.11)

2.53 (0.84; 7.59)

7 (19%)

2.28 (0.61; 8.49)

2.72 (0.67; 11.09)

14 (26%)

11.90*(2.57; 55.08)

13.88*(2.78; 67.23)

Clinical characteristics

Comorbidity

 No comorbidity

8 (20%)

1.00

1.00

6 (19%)

1.00

1.00

4 (14%)

1. 00

1.00

4 (10%)

1.00

1.00

 Yes comorbidity

15 (16%)

0.79 (0.30; 2.07)

1.35 (0.45; 4.05)

12 (18%)

0.93 (0.31; 2.75)

1.33 (0.40; 4.38)

7 (14%)

1.02 (0.27; 3.82)

2.17 (0.43; 10.91)

12 (14%)

1.46 (0.44; 4.85)

3.51 (0.82; 15.09)

Treatment

Surgery

 No surgery

3 (9%)

1.00

1.00

3 (21%)

1.00

1.00

3 (20%)

0.55

1.00

3 (9%)

1.00

1.00

 Surgery

20 (21%)

2.72 (0.75; 9.81)

2.98 (0.35; 25.77)

15 (17%)

0.76 (0.19; 3.07)

1.21 (0.12; 12.24)

8 (12%)

0.54 (0.13; 2.35)

0.63 (0.02; 15.89)

13 (14%)

1.66 (0.44; 6.22)

3.30 (0.23; 46.73)

Radiation

 No radiation

10 (20%)

1.00

1.00

10 (30%)

1.00

1.00

2 (15%)

1.00

1.00

7 (14%)

1.00

1.00

 Radiation

13 (16%)

0.81 (0.32; 2.01)

0.73 (0.26; 2.01)

8 (12%)

0.31*(0.11; 0.87)

0.33 (0.11; 1.01)

9 (13%)

0.83 (0.16; 4.35)

0.75 (0.13; 4.42)

9 (12%)

0.83 (0.29; 2.40)

0.93 (0.28; 3.11)

Chemotherapy

 No chemotherapy

8 (13%)

1.00

1.00

7 (17%)

1.00

1.00

5 (14%)

1.00

1.00

8 (13%)

1.00

1.00

 Chemotherapy

15 (22%)

1.91 (0.75; 4.88)

1.10 (0.30; 4.06)

11 (18%)

1.09 (0.38; 3.09)

1.21 (0.31; 4.82)

6 (13%)

0.98 (0.27; 3.53)

1.15 (0.18; 7.53)

8 (12%)

0.93 (0.33; 2.65)

0.43 (0.08; 2.26)

Hormones

 No hormones

8 (27%)

1.00

1.00

6 (26%)

1.00

1.00

3 (19%)

1.00

1.00

3 (10%)

1.00

1.00

 Hormones

15 (15%)

0.49 (0.18; 1.29)

0.45 (0.15; 1.33)

12 (15%)

0.52 (0.17; 1.57)

0.50 (0.15; 1.67)

8 (12%)

0.60 (0.14; 2.57)

0.50 (0.10; 2.52)

13 (13%)

1.31 (0.35; 4.95)

1.38 (0.30; 6.40)

Years since diagnosis

 <3 years

11 (18%)

1.00

1.00

7 (16%)

1.00

1.00

6 (15%)

1.00

1.00

9 (16%)

1.00

1.00

 ≥3 years

12 (17%)

0.92 (0.37; 2.27)

0.99(0.35; 2.78)

11 (19%)

1.26 (0.45;3.58)

1.65(0.50; 5.47)

5 (12%)

0.81 (0.23; 2.90)

1.00 (0.24; 4.15)

7 (10%)

0.60 (0.21; 1.74)

0.81(0.23; 2.87)

  1. aAdjusted for age, gender and education, * P < 0.050, #Consists of 102 patient responses, ##Consists of 82 patient responses, ###Consists 129 patient responses.